Investment Into the U.S. in AI, Biotech Has Dropped, Says Qiming Venture's Leung

The video discusses the impact of the US-China trade war on investment strategies, focusing on sectors like e-commerce, biotech, and AI. It highlights regulatory challenges, such as the scivias regulation and Huawei's arrest, affecting risk appetite. The video also explores how US policies may spur innovation in China, with increased R&D efforts. Global collaboration is emphasized, despite challenges. The IPO market outlook is cautiously optimistic, with a strong pipeline in various sectors. Overall, the speaker is optimistic in the medium term but cautious in the short term.

What impact do the US regulations have on innovation in China according to the speaker?

What is the current outlook for the IPO market in China and the US as discussed in the text?